Fibroadenoma interventions: Difference between revisions
| Line 25: | Line 25: | ||
===Observation=== | ===Observation=== | ||
* Most fibroadenomas are managed conservatively with yearly breast examination and ultrasound if necessary. This is related to the fact that about 10 to 40% of fibroadenomas regress spontaneously. | * Most fibroadenomas are managed conservatively with yearly breast examination and ultrasound if necessary. This is related to the fact that about 10 to 40% of fibroadenomas regress spontaneously.<ref name="pmid26366109">{{cite journal| author=Lee M, Soltanian HT| title=Breast fibroadenomas in adolescents: current perspectives. | journal=Adolesc Health Med Ther | year= 2015 | volume= 6 | issue= | pages= 159-63 | pmid=26366109 | doi=10.2147/AHMT.S55833 | pmc=4562655 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26366109 }} </ref> | ||
* Reasons to undergo intervention of a fibroadenoma: | * Reasons to undergo intervention of a fibroadenoma:<ref name="pmid26366109">{{cite journal| author=Lee M, Soltanian HT| title=Breast fibroadenomas in adolescents: current perspectives. | journal=Adolesc Health Med Ther | year= 2015 | volume= 6 | issue= | pages= 159-63 | pmid=26366109 | doi=10.2147/AHMT.S55833 | pmc=4562655 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26366109 }} </ref> | ||
:* Significant anxiety in a patient (despite knowing that the lesion has a low malignant potential) | :* Significant anxiety in a patient (despite knowing that the lesion has a low malignant potential) | ||
:* Mass is greater than 5 cm in size | :* Mass is greater than 5 cm in size | ||
| Line 37: | Line 37: | ||
:* High malignant potential | :* High malignant potential | ||
:* Presence of a high risk genetic mutation or syndrome | :* Presence of a high risk genetic mutation or syndrome | ||
:* Complex fibroadenoma | |||
==References== | ==References== | ||
Revision as of 20:23, 31 January 2019
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma interventions On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma interventions |
|
Risk calculators and risk factors for Fibroadenoma interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
There are no recommended therapeutic interventions for the management of [disease name].
OR
[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
OR
[Name of intervention] is the mainstay of treatment for [disease or malignancy].
Indications
Observation
- Most fibroadenomas are managed conservatively with yearly breast examination and ultrasound if necessary. This is related to the fact that about 10 to 40% of fibroadenomas regress spontaneously.[1]
- Reasons to undergo intervention of a fibroadenoma:[1]
- Significant anxiety in a patient (despite knowing that the lesion has a low malignant potential)
- Mass is greater than 5 cm in size
- Rapidly enlarging size
- Intense pain
- Distortion of breast parenchyma
- Cosmetic issues
- Persistent mass with no regression
- Hypercellular stroma on ultrasound
- High malignant potential
- Presence of a high risk genetic mutation or syndrome
- Complex fibroadenoma
References
- ↑ 1.0 1.1 Lee M, Soltanian HT (2015). "Breast fibroadenomas in adolescents: current perspectives". Adolesc Health Med Ther. 6: 159–63. doi:10.2147/AHMT.S55833. PMC 4562655. PMID 26366109.